ArticleFrontiers in cellular and infection microbiology2026
Defining reference values for the gut microbiota in a Southern European population.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The clinical implementation of gut microbiota analysis requires the definition of reliable reference values derived from standardized and certified methodologies applied to a population representative of the intended clinical setting. Methods: In this study, 250 fecal samples were analyzed using a CE-certified 16S rRNA bacterial profiling assay for taxonomic characterization across multiple bacterial levels. Sequencing reads were quality-filtered and aligned against the RDP database (release 11, update 5); only sequences with ≥80% alignment coverage and ≥97% similarity were retained. Results: The resulting taxonomic distributions were first compared with data previously obtained from a similar population, revealing only minor differences. As an additional validation, comparative analyses were performed with data from a clinical study on fecal microbiota transplantation (FMT). Donor profiles were highly consistent with those obtained in the present study, whereas pre-transplant samples showed marked deviations from the reference ranges; post-transplant profiles progressively converged toward them. Discussion: Although the limited sample size precludes accurate assessment of rare taxa (<0.1% relative abundance), the use of a single Next-Generation Sequencing (NGS) platform and the focus on a Southern European population characterized by the Mediterranean diet allowed the establishment of the first set of gut microbiota reference values derived from a certified
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.